MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ijc.34009

Медицинская библиотека · International journal of cancer · 2022

Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Clasen Joanna L, Heath Alicia K, Van Puyvelde Heleen, Huybrechts Inge, Park Jin Young, Ferrari Pietro, Scelo Ghislaine, Ulvik Arve, Midttun Øivind, Ueland Per Magne, Overvad Kim, Eriksen Anne Kirstine, Tjønneland Anne, Kaaks Rudolf, Katzke Verena, Schulze Matthias B, Palli Domenico, Agnoli Claudia, Chiodini Paolo, Tumino Rosario, Sacerdote Carlotta, Zamora-Ros Raul, Rodriguez-Barranco Miguel, Santiuste Carmen, Ardanaz Eva, Amiano Pilar, Schmidt Julie A, Weiderpass Elisabete, Gunter Marc, Riboli Elio, Cross Amanda J, Johansson Mattias, Muller David C

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Previous studies have suggested that components of one-carbon metabolism, particularly circulating vitamin B6, have an etiological role in renal cell carcinoma (RCC). Vitamin B6 is a cofactor in the transsulfuration pathway. We sought to holistically investigate the role of the transsulfuration pathway in RCC risk. We conducted a nested case-control study (455 RCC cases and 455 matched controls) within the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Plasma samples from the baseline visit were analyzed for metabolites of the transsulfuration pathway, including pyridoxal 5'-phosphate (PLP, the biologically active form of vitamin B6), homocysteine, serine, cystathionine, and cysteine, in addition to folate. Bayesian conditional logistic regression was used to estimate associations of metabolites with RCC risk as well as interactions with established RCC risk factors. Circulating PLP and cysteine were inversely associated with RCC risk, and these associations were not attenuated after adjustment for other transsulfuration metabolites (odds ratio (OR) and 90% credible interval (CrI) per 1 SD increase in log concentration: 0.76 [0.66, 0.87]; 0.81 [0.66, 0.96], respectively). A comparison of joint metabolite profiles suggested substantially greater RCC risk for the profile representative of low overall transsulfuration function compared to high function (OR 2.70 [90% CrI 1.26, 5.70]). We found some statistical evidence of interactions of cysteine with body mass index, and PLP and homocysteine with smoking status, on their associations with RCC risk. In conclusion, we found evidence suggesting that the transsulfuration pathway may play a role in metabolic dysregulation leading to RCC development.

Для цитирования: Clasen Joanna L, Heath Alicia K, Van Puyvelde Heleen, Huybrechts Inge, Park Jin Young, Ferrari Pietro, Scelo Ghislaine, Ulvik Arve, Midttun Øivind, Ueland Per Magne, Overvad Kim, Eriksen Anne Kirstine, Tjønneland Anne, Kaaks Rudolf, Katzke Verena, Schulze Matthias B, Palli Domenico, Agnoli Claudia, Chiodini Paolo, Tumino Rosario, Sacerdote Carlotta, Zamora-Ros Raul, Rodriguez-Barranco Miguel, Santiuste Carmen, Ardanaz Eva, Amiano Pilar, Schmidt Julie A, Weiderpass Elisabete, Gunter Marc, Riboli Elio, Cross Amanda J, Johansson Mattias, Muller David C. Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.. International journal of cancer. 2022. DOI: 10.1002/ijc.34009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.